Drug Shortage Report for PEGALAX
| Report ID | 165841 |
| Drug Identification Number | 02328232 |
| Brand name | PEGALAX |
| Common or Proper name | polyethylene glycol 3350 |
| Company Name | ARALEZ PHARMACEUTICALS CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | POLYETHYLENE GLYCOL 3350 |
| Strength(s) | 100% |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | ORAL ORAL |
| Packaging size | carton of 14 sachets |
| ATC code | A06AD |
| ATC description | DRUGS FOR CONSTIPATION |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-07-28 |
| Estimated end date | 2022-09-27 |
| Actual end date | 2022-09-23 |
| Shortage status | Resolved |
| Updated date | 2022-09-26 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6733 MISSISSAUGA RD MISSISSAUGA, ONTARIO CANADA L5N 6J5 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2022-09-26 | French | Compare |
| v5 | 2022-09-26 | English | Compare |
| v4 | 2022-09-13 | French | Compare |
| v3 | 2022-09-13 | English | Compare |
| v2 | 2022-08-01 | French | Compare |
| v1 | 2022-08-01 | English | Compare |
Showing 1 to 6 of 6